Formulation and Pharmacological Studies of Leaves of Moringa (Moringa oleifera), a Novel Hepatoprotection in Oral Drug Formulations
BACKGROUND: Moringa oleifera, Moringaceae, is a tree that is native to South East Asia. Various parts of this tree are commonly used in traditional medicine to treat inflammation, hepatitis, gastric ulcer, and other ailments. AIM: M. oleifera leaves extract was formulated into stable suspensions, ch...
Gespeichert in:
Veröffentlicht in: | Open access Macedonian journal of medical sciences 2021-04, Vol.9 (A), p.151-156 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 156 |
---|---|
container_issue | A |
container_start_page | 151 |
container_title | Open access Macedonian journal of medical sciences |
container_volume | 9 |
creator | Aristianti, Aristianti Nurkhaeri, Nurkhaeri Tandiarrang, Vanny Y. Awaluddin, Akbar Muslimin, Lukman |
description | BACKGROUND: Moringa oleifera, Moringaceae, is a tree that is native to South East Asia. Various parts of this tree are commonly used in traditional medicine to treat inflammation, hepatitis, gastric ulcer, and other ailments. AIM: M. oleifera leaves extract was formulated into stable suspensions, characterized, and then evaluated for hepatoprotection activity against isoniazid. MATERIALS AND METHODS: The leaves were extracted using cold maceration, and suspensions of extract were prepared using sodium carboxymethyl cellulose (Na-CMC) as suspension agent at various concentrations (0.1, 0.5, and 1.0%). The formulations were analyzed by their appearance, color, odor, and taste. Density, pH, viscosity, re-dispersibility test, and sedimentation volume were observed. The stability of oral suspensions was analyzed in accelerated studies (5°C ± 2°C and 35°C ± 2°C for 12 h for 7 cycles) to find stable formulation, while the hepatoprotection activity was analyzed using an in vivo isoniazid-induced model. RESULTS: The appearance, color, odor, and taste of the suspensions were shown to be characteristic of the extract. Na-CMC at concentration 0.5% showed good physical properties. Stable suspension at dose 400 mg/kg BW per oral for 28 days exhibited a significant (p < 0.05) decrease in the serum glutamate oxaloacetate transaminase and serum glutamate pyruvate transaminase. CONCLUSION: Suspension containing M. oleifera leaves extract at 50 mg/5 mL was successfully obtained and showed physical properties that were appropriate and characteristic of this dosage form, suitable for hepatoprotection (400 mg/kg BW), making this an alternative to tablets. |
doi_str_mv | 10.3889/oamjms.2021.5839 |
format | Article |
fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_3889_oamjms_2021_5839</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3889_oamjms_2021_5839</sourcerecordid><originalsourceid>FETCH-LOGICAL-c889-de53ed7aecd6cd1edc90ea075185eb28e3c25f41c6e599406cd1fbcd27cc49393</originalsourceid><addsrcrecordid>eNpNkE1Lw0AURQdRsNTuXc5SwdT56CSZpVRrhWoFuw-vMy91SpIpM2nBtX_cxCp09e7icS73EHLN2Vjmub73UG_rOBZM8LHKpT4jA56rLNGpUucn-ZKMYtwyxrjSKRdiQL5nPtT7ClrnGwqNpe-fEGowvvIbZ6CiH-3eOozUl3SBcDimVx9cswF68x98ha7EALd3FOibP2BF57iD1u-Cb9H80l1Dl6EjPob9hp7UxityUUIVcfR3h2Q1e1pN58li-fwyfVgkptuYWFQSbQZobGosR2s0Q2CZ6tbhWuQojVDlhJsUldYT1j-Va2NFZsxESy2HhB2xJvgYA5bFLrgawlfBWdFrLI4ai15j0WuUP8nYaoI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Formulation and Pharmacological Studies of Leaves of Moringa (Moringa oleifera), a Novel Hepatoprotection in Oral Drug Formulations</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Aristianti, Aristianti ; Nurkhaeri, Nurkhaeri ; Tandiarrang, Vanny Y. ; Awaluddin, Akbar ; Muslimin, Lukman</creator><creatorcontrib>Aristianti, Aristianti ; Nurkhaeri, Nurkhaeri ; Tandiarrang, Vanny Y. ; Awaluddin, Akbar ; Muslimin, Lukman</creatorcontrib><description>BACKGROUND: Moringa oleifera, Moringaceae, is a tree that is native to South East Asia. Various parts of this tree are commonly used in traditional medicine to treat inflammation, hepatitis, gastric ulcer, and other ailments. AIM: M. oleifera leaves extract was formulated into stable suspensions, characterized, and then evaluated for hepatoprotection activity against isoniazid. MATERIALS AND METHODS: The leaves were extracted using cold maceration, and suspensions of extract were prepared using sodium carboxymethyl cellulose (Na-CMC) as suspension agent at various concentrations (0.1, 0.5, and 1.0%). The formulations were analyzed by their appearance, color, odor, and taste. Density, pH, viscosity, re-dispersibility test, and sedimentation volume were observed. The stability of oral suspensions was analyzed in accelerated studies (5°C ± 2°C and 35°C ± 2°C for 12 h for 7 cycles) to find stable formulation, while the hepatoprotection activity was analyzed using an in vivo isoniazid-induced model. RESULTS: The appearance, color, odor, and taste of the suspensions were shown to be characteristic of the extract. Na-CMC at concentration 0.5% showed good physical properties. Stable suspension at dose 400 mg/kg BW per oral for 28 days exhibited a significant (p < 0.05) decrease in the serum glutamate oxaloacetate transaminase and serum glutamate pyruvate transaminase. CONCLUSION: Suspension containing M. oleifera leaves extract at 50 mg/5 mL was successfully obtained and showed physical properties that were appropriate and characteristic of this dosage form, suitable for hepatoprotection (400 mg/kg BW), making this an alternative to tablets.</description><identifier>ISSN: 1857-9655</identifier><identifier>EISSN: 1857-9655</identifier><identifier>DOI: 10.3889/oamjms.2021.5839</identifier><language>eng</language><ispartof>Open access Macedonian journal of medical sciences, 2021-04, Vol.9 (A), p.151-156</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c889-de53ed7aecd6cd1edc90ea075185eb28e3c25f41c6e599406cd1fbcd27cc49393</citedby><cites>FETCH-LOGICAL-c889-de53ed7aecd6cd1edc90ea075185eb28e3c25f41c6e599406cd1fbcd27cc49393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Aristianti, Aristianti</creatorcontrib><creatorcontrib>Nurkhaeri, Nurkhaeri</creatorcontrib><creatorcontrib>Tandiarrang, Vanny Y.</creatorcontrib><creatorcontrib>Awaluddin, Akbar</creatorcontrib><creatorcontrib>Muslimin, Lukman</creatorcontrib><title>Formulation and Pharmacological Studies of Leaves of Moringa (Moringa oleifera), a Novel Hepatoprotection in Oral Drug Formulations</title><title>Open access Macedonian journal of medical sciences</title><description>BACKGROUND: Moringa oleifera, Moringaceae, is a tree that is native to South East Asia. Various parts of this tree are commonly used in traditional medicine to treat inflammation, hepatitis, gastric ulcer, and other ailments. AIM: M. oleifera leaves extract was formulated into stable suspensions, characterized, and then evaluated for hepatoprotection activity against isoniazid. MATERIALS AND METHODS: The leaves were extracted using cold maceration, and suspensions of extract were prepared using sodium carboxymethyl cellulose (Na-CMC) as suspension agent at various concentrations (0.1, 0.5, and 1.0%). The formulations were analyzed by their appearance, color, odor, and taste. Density, pH, viscosity, re-dispersibility test, and sedimentation volume were observed. The stability of oral suspensions was analyzed in accelerated studies (5°C ± 2°C and 35°C ± 2°C for 12 h for 7 cycles) to find stable formulation, while the hepatoprotection activity was analyzed using an in vivo isoniazid-induced model. RESULTS: The appearance, color, odor, and taste of the suspensions were shown to be characteristic of the extract. Na-CMC at concentration 0.5% showed good physical properties. Stable suspension at dose 400 mg/kg BW per oral for 28 days exhibited a significant (p < 0.05) decrease in the serum glutamate oxaloacetate transaminase and serum glutamate pyruvate transaminase. CONCLUSION: Suspension containing M. oleifera leaves extract at 50 mg/5 mL was successfully obtained and showed physical properties that were appropriate and characteristic of this dosage form, suitable for hepatoprotection (400 mg/kg BW), making this an alternative to tablets.</description><issn>1857-9655</issn><issn>1857-9655</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpNkE1Lw0AURQdRsNTuXc5SwdT56CSZpVRrhWoFuw-vMy91SpIpM2nBtX_cxCp09e7icS73EHLN2Vjmub73UG_rOBZM8LHKpT4jA56rLNGpUucn-ZKMYtwyxrjSKRdiQL5nPtT7ClrnGwqNpe-fEGowvvIbZ6CiH-3eOozUl3SBcDimVx9cswF68x98ha7EALd3FOibP2BF57iD1u-Cb9H80l1Dl6EjPob9hp7UxityUUIVcfR3h2Q1e1pN58li-fwyfVgkptuYWFQSbQZobGosR2s0Q2CZ6tbhWuQojVDlhJsUldYT1j-Va2NFZsxESy2HhB2xJvgYA5bFLrgawlfBWdFrLI4ai15j0WuUP8nYaoI</recordid><startdate>20210412</startdate><enddate>20210412</enddate><creator>Aristianti, Aristianti</creator><creator>Nurkhaeri, Nurkhaeri</creator><creator>Tandiarrang, Vanny Y.</creator><creator>Awaluddin, Akbar</creator><creator>Muslimin, Lukman</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20210412</creationdate><title>Formulation and Pharmacological Studies of Leaves of Moringa (Moringa oleifera), a Novel Hepatoprotection in Oral Drug Formulations</title><author>Aristianti, Aristianti ; Nurkhaeri, Nurkhaeri ; Tandiarrang, Vanny Y. ; Awaluddin, Akbar ; Muslimin, Lukman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c889-de53ed7aecd6cd1edc90ea075185eb28e3c25f41c6e599406cd1fbcd27cc49393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Aristianti, Aristianti</creatorcontrib><creatorcontrib>Nurkhaeri, Nurkhaeri</creatorcontrib><creatorcontrib>Tandiarrang, Vanny Y.</creatorcontrib><creatorcontrib>Awaluddin, Akbar</creatorcontrib><creatorcontrib>Muslimin, Lukman</creatorcontrib><collection>CrossRef</collection><jtitle>Open access Macedonian journal of medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aristianti, Aristianti</au><au>Nurkhaeri, Nurkhaeri</au><au>Tandiarrang, Vanny Y.</au><au>Awaluddin, Akbar</au><au>Muslimin, Lukman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Formulation and Pharmacological Studies of Leaves of Moringa (Moringa oleifera), a Novel Hepatoprotection in Oral Drug Formulations</atitle><jtitle>Open access Macedonian journal of medical sciences</jtitle><date>2021-04-12</date><risdate>2021</risdate><volume>9</volume><issue>A</issue><spage>151</spage><epage>156</epage><pages>151-156</pages><issn>1857-9655</issn><eissn>1857-9655</eissn><abstract>BACKGROUND: Moringa oleifera, Moringaceae, is a tree that is native to South East Asia. Various parts of this tree are commonly used in traditional medicine to treat inflammation, hepatitis, gastric ulcer, and other ailments. AIM: M. oleifera leaves extract was formulated into stable suspensions, characterized, and then evaluated for hepatoprotection activity against isoniazid. MATERIALS AND METHODS: The leaves were extracted using cold maceration, and suspensions of extract were prepared using sodium carboxymethyl cellulose (Na-CMC) as suspension agent at various concentrations (0.1, 0.5, and 1.0%). The formulations were analyzed by their appearance, color, odor, and taste. Density, pH, viscosity, re-dispersibility test, and sedimentation volume were observed. The stability of oral suspensions was analyzed in accelerated studies (5°C ± 2°C and 35°C ± 2°C for 12 h for 7 cycles) to find stable formulation, while the hepatoprotection activity was analyzed using an in vivo isoniazid-induced model. RESULTS: The appearance, color, odor, and taste of the suspensions were shown to be characteristic of the extract. Na-CMC at concentration 0.5% showed good physical properties. Stable suspension at dose 400 mg/kg BW per oral for 28 days exhibited a significant (p < 0.05) decrease in the serum glutamate oxaloacetate transaminase and serum glutamate pyruvate transaminase. CONCLUSION: Suspension containing M. oleifera leaves extract at 50 mg/5 mL was successfully obtained and showed physical properties that were appropriate and characteristic of this dosage form, suitable for hepatoprotection (400 mg/kg BW), making this an alternative to tablets.</abstract><doi>10.3889/oamjms.2021.5839</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1857-9655 |
ispartof | Open access Macedonian journal of medical sciences, 2021-04, Vol.9 (A), p.151-156 |
issn | 1857-9655 1857-9655 |
language | eng |
recordid | cdi_crossref_primary_10_3889_oamjms_2021_5839 |
source | EZB-FREE-00999 freely available EZB journals |
title | Formulation and Pharmacological Studies of Leaves of Moringa (Moringa oleifera), a Novel Hepatoprotection in Oral Drug Formulations |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T09%3A27%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Formulation%20and%20Pharmacological%20Studies%20of%20Leaves%20of%20Moringa%20(Moringa%20oleifera),%20a%20Novel%20Hepatoprotection%20in%20Oral%20Drug%20Formulations&rft.jtitle=Open%20access%20Macedonian%20journal%20of%20medical%20sciences&rft.au=Aristianti,%20Aristianti&rft.date=2021-04-12&rft.volume=9&rft.issue=A&rft.spage=151&rft.epage=156&rft.pages=151-156&rft.issn=1857-9655&rft.eissn=1857-9655&rft_id=info:doi/10.3889/oamjms.2021.5839&rft_dat=%3Ccrossref%3E10_3889_oamjms_2021_5839%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |